Literature DB >> 1929036

Serum cholesterol as a prognostic factor after myocardial infarction: the Framingham Study.

N D Wong1, P W Wilson, W B Kannel.   

Abstract

OBJECTIVE: To determine the relation between serum cholesterol levels and the long-term risk for reinfarction, death from coronary heart disease, and all-cause mortality in persons who recover from myocardial infarction.
DESIGN: Prospective, longitudinal study.
SETTING: A geographically defined population-based cohort of adults participating in the Framingham Heart Study. PATIENTS: Men (n = 260) and women (n = 114), 33 to 88 years of age (mean age, 62 years), who had a history of myocardial infarction. MEASUREMENTS: A complete physical examination, including electrocardiographic evaluation, blood pressure measurement, height and weight measurements, determination of smoking habits, and casual determinations of blood glucose and serum cholesterol, was done approximately 1 year after recovery from initial myocardial infarction. Patients were followed after infarction for the occurrence of reinfarction or death (mean follow-up, 10.5 years; range, 0.8 to 31.6 years). MAIN
RESULTS: The mean cholesterol level after infarction was 5.21 mmol/L (242.8 mg/dL); 20% of patients had levels below 5.17 mmol/L (200 mg/dL), and 22% had levels of 7.11 mmol/L (275 mg/dL) or more. Compared with patients who had cholesterol levels below 5.17 mmol/L, patients with levels of 7.11 mmol/L or more were at increased risk for reinfarction (relative risk, 3.8; 95% Cl, 1.6 to 8.7), death from coronary heart disease (relative risk, 2.6; Cl, 1.4 to 4.8), and all-cause mortality (relative risk, 1.9; Cl, 1.2 to 2.9) based on multivariate Cox regression analyses adjusted for other coronary risk factors. Intermediate cholesterol levels (5.17 mmol/L to 7.11 mmol/L) were generally not associated with increased risk. The association between elevated serum cholesterol and increased risk was strongest in men; however, elevated cholesterol levels were found to be most strongly related to death from coronary disease and to all-cause mortality in persons who were 65 years of age or more.
CONCLUSIONS: Patients who have recovered from a myocardial infarction and who have high cholesterol levels are at an increased long-term risk for reinfarction, death from coronary heart disease, and all-cause mortality. Our results confirm the prognostic value of cholesterol levels measured after myocardial infarction and support the role of lipid management in this population.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1929036     DOI: 10.7326/0003-4819-115-9-687

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  31 in total

Review 1.  Lipids and the elderly.

Authors:  Wilbert S Aronow
Journal:  Rev Endocr Metab Disord       Date:  2004-12       Impact factor: 6.514

Review 2.  Low-density lipoprotein cholesterol, apolipoprotein B, and risk of coronary heart disease: from familial hyperlipidemia to genomics.

Authors:  Christopher C Imes; Melissa A Austin
Journal:  Biol Res Nurs       Date:  2012-04-23       Impact factor: 2.522

3.  Human genetics as a foundation for innovative drug development.

Authors:  Alexander Kamb; Sean Harper; Kari Stefansson
Journal:  Nat Biotechnol       Date:  2013-11       Impact factor: 54.908

4.  Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association.

Authors:  Jerome L Fleg; Daniel E Forman; Kathy Berra; Vera Bittner; James A Blumenthal; Michael A Chen; Susan Cheng; Dalane W Kitzman; Mathew S Maurer; Michael W Rich; Win-Kuang Shen; Mark A Williams; Susan J Zieman
Journal:  Circulation       Date:  2013-10-28       Impact factor: 29.690

5.  Cost effectiveness of lopinavir/ritonavir compared with atazanavir in antiretroviral-naive patients: modelling the combined effects of HIV and heart disease.

Authors:  Kit N Simpson; Michelle P Luo; Elinor C Chumney; Martin S King; Scott Brun
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

Review 6.  Treating to protect: current cardiovascular treatment approaches and remaining needs.

Authors:  Michael Böhm; Christian Werner; Anne Jakobsen; Jose Heroys; Ann Ralph; Tomas Rees; Michael Shaw
Journal:  Medscape J Med       Date:  2008-03-26

7.  Effect of Persistence with Drug Therapy On the Risk of Myocardial Re-infarction.

Authors:  Fadia T Shaya; Anna Gu; Xia Yan
Journal:  P T       Date:  2008-05

8.  Multiple cardiovascular disease risk factors in Canadian adults. Canadian Heart Health Surveys Research Group.

Authors:  S MacDonald; M R Joffres; S Stachenko; L Horlick; G Fodor
Journal:  CMAJ       Date:  1992-06-01       Impact factor: 8.262

9.  Cardiovascular risk determination: discrepancy between total cholesterol evaluation and two compound laboratory indices in Norway.

Authors:  J E Berg; A T Høstmark
Journal:  J Epidemiol Community Health       Date:  1994-08       Impact factor: 3.710

Review 10.  Cholesterol in patients with coronary heart disease: how low should we go?

Authors:  H B Rubins
Journal:  J Gen Intern Med       Date:  1995-08       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.